139 related articles for article (PubMed ID: 18261009)
1. [Efficacy of long-term therapy with trimetazidine in patients with ischemic heart disease in combination with chronic obstructive pulmonary disease].
Kolomoets NM; Baksheev VI; Zarubina EG; Uvaĭsova IU
Kardiologiia; 2008; 48(2):47-51. PubMed ID: 18261009
[No Abstract] [Full Text] [Related]
2. [Clinical efficacy of myocardial cytoprotector trimetazidine in peri- and postmenopausal women with ischemic heart disease].
Churshin AD; Pimenov LT
Kardiologiia; 2003; 43(8):31-5. PubMed ID: 14593380
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of Efficacy and Safety of Metabolic Therapy With Trimetazidine MB in Patients With Ischemic Heart Disease and Chronic Heart Failure].
Gorbunova ML; Vilkova AV
Kardiologiia; 2016 Mar; 56(3):67-72. PubMed ID: 28294892
[TBL] [Abstract][Full Text] [Related]
4. [Correction of episodes of transitory myocardial ischemia with trimetazidine in patients with ischemic heart disease combined with type 2 diabetes mellitus].
Petriĭ VV; Mikova NV; Makolkin VI
Kardiologiia; 2007; 47(7):22-5. PubMed ID: 18260890
[TBL] [Abstract][Full Text] [Related]
5. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
Belardinelli R
Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
[TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
[TBL] [Abstract][Full Text] [Related]
7. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
[TBL] [Abstract][Full Text] [Related]
8. [Trimetazidine in correction of chronic heart failure in patients with ischemic heart disease].
Nedoshivin AO; Kutuzova AE; Nesterova IV; Mikhaĭlova IE; Rubashkina EI; Novikova NA; Liasnikova EA; Perepech NB
Kardiologiia; 2002; 42(3):12-5. PubMed ID: 12494179
[TBL] [Abstract][Full Text] [Related]
9. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
Kalinina EB; Komissarova IA; Zaslavskaia RM; Zhdanov IuA
Klin Med (Mosk); 2002; 80(5):50-3. PubMed ID: 12087889
[TBL] [Abstract][Full Text] [Related]
10. Role of trimetazidine in management of ischemic cardiomyopathy.
Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC
Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202
[TBL] [Abstract][Full Text] [Related]
11. [Trimetazidine (Preductal). A new approach in controlling myocardial ischemia].
Eliseev OM
Ter Arkh; 1996; 68(8):57-63. PubMed ID: 9019836
[No Abstract] [Full Text] [Related]
12. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease.
Rosano GM; Marazzi G; Patrizi R; Cerquetani E; Vitale C; Volterrani M; Fini M; Mercuro G
Am J Cardiol; 2005 Feb; 95(3):327-31. PubMed ID: 15670539
[TBL] [Abstract][Full Text] [Related]
13. [Significance of trimetazidine for out of hospital physical rehabilitation after myocardial infarction].
Aronov DM; Tartakovskiĭ LB; Novikova NK; Pisareva NA; Smolenskiĭ VS; Zhidko NI
Kardiologiia; 2002; 42(11):14-20. PubMed ID: 12494029
[No Abstract] [Full Text] [Related]
14. Influence of trimetazidine and ranolazine on endothelial function in patients with ischemic heart disease.
Rehberger-Likozar A; Šebeštjen M
Coron Artery Dis; 2015 Dec; 26(8):651-6. PubMed ID: 26049922
[TBL] [Abstract][Full Text] [Related]
15. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
Sisakian AS; Torgomian AL; Barkhudarian AL
Klin Med (Mosk); 2006; 84(10):55-8. PubMed ID: 17201276
[TBL] [Abstract][Full Text] [Related]
16. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
[TBL] [Abstract][Full Text] [Related]
17. [Myocardial cytoprotection with trimetazidine in patients with ischemic heart disease during surgical stress].
Afanas'eva IV; Goncharova LL; Miroshnichenko AG; Petrash VV; Pokrovskaia LA
Vestn Khir Im I I Grek; 1999; 158(5):34-7. PubMed ID: 10645577
[TBL] [Abstract][Full Text] [Related]
18. Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.
Stanley WC; Sabbah HN
Heart Fail Rev; 2005 Dec; 10(4):275-9. PubMed ID: 16583175
[No Abstract] [Full Text] [Related]
19. Trimetazidine improves myocardial perfusion and left ventricular function in ischemic left ventricular dysfunction.
Feola M; Biggi A; Francini A; Leonardi G; Ribichini F; Ferrero V; Uslenghi E
Clin Nucl Med; 2004 Feb; 29(2):117-8. PubMed ID: 14734913
[No Abstract] [Full Text] [Related]
20. Metabolic treatment of myocardial ischaemia.
Ferrari R
Eur Heart J; 1999 Aug; 20(16):1144-5. PubMed ID: 10448019
[No Abstract] [Full Text] [Related]
[Next] [New Search]